Data as of Q4 2025 (Dec 31, 2025)

Tyro Capital Management LLC

โ€ขCIK: 1915395โ€ขFiling: Q4 2025

**Tyro Capital Management LLC** manages $423M across a concentrated portfolio of 12 positions. The fund exhibits significant conviction in its top holdings, notably allocating $124.8M to BX and $78.5M to RJF. Further substantial exposure includes $40.1M in SF-PD and $39.9M in CRS, indicating a focus on specific sector opportunities. This structure suggests a highly targeted, opportunistic investment mandate within its current asset allocation.

Total AUM
$276.2M
+ $146.4M in options
QoQ Performance
+2.6%
Positions
10
+ 2 options
Top 10 Concentration
96.2%
Latest Filing
Q4 2025

Top Holdings Allocation

CRH
ESTA
SN
CRS
CROX
SPRY
OGM1
CRH29.5%
ESTA18.6%
SN9.5%
CRS9.4%
CROX7.4%
SPRY5.5%
OGM15.1%
ROAD4.2%

๐Ÿ“ˆ Biggest Buys

CRHCALL
CRH PLC
+177.4%
29.5% of portfolio
SPRY
ARS PHARMACEUTICALS INC
NEW
5.5% of portfolio
QURE
UNIQURE NV
NEW
3.8% of portfolio
SN
SHARKNINJA INC
+53.9%
9.5% of portfolio
CELH
CELSIUS HLDGS INC
NEW
3.2% of portfolio

๐Ÿ“‰ Biggest Sells

No reductions this quarter

Sector Breakdown

Other70.5%
Materials29.5%

๐Ÿšช Exited Positionssold since Q3 2025

GRPN
Groupon, Inc.
SOLD
$25.5M
HNGE
Hinge Health, Inc.
SOLD
$15.7M
LENZ
Lenz Therapeutics, Inc.
SOLD
$4.7M

Changes from Q3 2025

NEW5 new positions
โ†‘6 increased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023